Analystreport

Avadel Pharmaceuticals (NASDAQ:AVDL) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $18.50 price target on the stock.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - american depositary shares each representing one ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com